Cargando…
In-vitro Activity of Delpazolid and Comparator Agents Against Methicillin-resistant Staphylococcus aureus Involved in Bloodstream Infection
Autores principales: | Park, Jeong Su, Choi, Yun Jung, Kwon, Kyungmi, Choi, Seong Jin, Moon, Song Mi, Song, Kyoung-Ho, Kim, Eu Suk, Park, Kyoung Un, Kim, Hong Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Laboratory Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989538/ https://www.ncbi.nlm.nih.gov/pubmed/36843409 http://dx.doi.org/10.3343/alm.2023.43.4.389 |
Ejemplares similares
-
Anti-Alpha-Toxin Antibody Responses and Clinical Outcomes of Staphylococcus aureus Bacteremia
por: Kim, Nak-Hyun, et al.
Publicado: (2023) -
Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary Tuberculosis
por: Kim, Ju Sang, et al.
Publicado: (2022) -
Prevalence and Characteristics of qacA/B-positive Methicillin-resistant Staphylococcus aureus (MRSA) Bloodstream Infection Isolates in a Tertiary Hospital
por: Cho, Oh-Hyun, et al.
Publicado: (2017) -
Methicillin-resistant Staphylococcus aureus screening is important for surgeons
por: Hyun, Il-Kwang, et al.
Publicado: (2019) -
Comparison of Methicillin-Resistant Staphylococcus aureus Community-Acquired and Healthcare-Associated Pneumonia
por: Leem, Ah Young, et al.
Publicado: (2014)